HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cyclosporine A prevents ex vivo PCO formation through induction of autophagy-mediated cell death.

Abstract
The purpose of this study was to determine the Cyclosporine A (CsA) dose and minimum drug delivery time needed to prevent posterior capsule opacification (PCO) in an ex vivo canine model and evaluate the mechanism of CsA-induced cell death. Canine lens epithelial cells (LEC) were treated with CsA and changes in cell migration, proliferation, and density were monitored over time. CsA-treated LEC underwent transmission electron microscopy (TEM), immunofluorescence, and immunoblotting in the presence or absence of autophagy inhibitors to evaluate the mechanism of cell death. Lens capsules were harvested from canine cadaver eyes for an ex vivo model of PCO. Lens capsules were treated with CsA for 1, 2, 3, 4, 5, 6, or 7 days, and subsequently maintained in culture for a total of 28 days in the absence of drug. CsA reduced LEC viability in a dose dependent manner. Morphologically, CsA-treated LEC were swollen, had intact nuclei, lacked peripheral chromatin condensation, and demonstrated prominent vacuolization; TEM revealed autophagosomes. LC3-II protein expression and acridine orange fluorescence increased in CsA-treated cells. A small non-significant induction of cleaved caspase-3 was observed in CsA-treated LEC. Lens capsules treated with 5, 6, or 7 days of 10 μg/mL CsA showed a significant decrease in ex vivo PCO formation; 6 days of drug delivery prevented PCO. This study finds that morphologic changes, formation of acidic vesicles, and increased expression of LC3-II supports the hypothesis that CsA mediates LEC death via autophagy; this is a novel finding in the lens. Induction of CsA-induced apoptosis was minimal. Six days of intracapsular CsA drug delivery prevented ex vivo PCO formation.
AuthorsHeather L Chandler, Kristen J Gervais, Elizabeth A Lutz, Elizabeth M Curto, Rachel B Matusow, David A Wilkie, Anne J Gemensky-Metzler
JournalExperimental eye research (Exp Eye Res) Vol. 134 Pg. 63-72 (May 2015) ISSN: 1096-0007 [Electronic] England
PMID25839646 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightPublished by Elsevier Ltd.
Chemical References
  • Immunosuppressive Agents
  • Microtubule-Associated Proteins
  • Cyclosporine
Topics
  • Animals
  • Autophagy (drug effects)
  • Capsule Opacification (metabolism, pathology, prevention & control)
  • Cell Count
  • Cell Death (drug effects)
  • Cell Movement (drug effects)
  • Cell Proliferation (drug effects)
  • Cyclosporine (administration & dosage, pharmacology)
  • Dogs
  • Electrophoresis, Polyacrylamide Gel
  • Epithelial Cells (drug effects, pathology)
  • Immunoblotting
  • Immunosuppressive Agents (administration & dosage, pharmacology)
  • Microscopy, Electron, Transmission
  • Microtubule-Associated Proteins (metabolism)
  • Organ Culture Techniques
  • Posterior Capsule of the Lens (drug effects, metabolism, ultrastructure)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: